Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A box of Moderna Spikevax (COVID-19 Vaccine, mRNA) is kept in the refrigerator at Skippack Pharmacy in Schwenksville, ...

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...

A group of experts that advises the US Centers for Disease Control and Prevention on its vaccine recommendations has suspended an anticipated push to stop recommending mRNA-based Covid-19 vaccines ...

Ongoing federal support for mRNA technology and research could make good on a longstanding presidential promise to cure cancer, according to Jeff Coller, Bloomberg Distinguished Professor of RNA ...

A patent dispute over technology key to messenger RNA Covid-19 vaccines is settling with Moderna agreeing to pay $950 million up front and potentially more than $1 billion later, a resolution that ...

Add Yahoo as a preferred source to see more of our stories on Google. A nurse draws up doses of the Moderna COVID-19 for a vaccination clinic in St. Helena in 2021. Moderna is offering a new, low-dose ...

Co‑injecting three common amino acids with LNPs dramatically boosted both mRNA delivery and CRISPR gene editing efficiency in preclinical models.

The same technology used in COVID-19 vaccines could help prevent muscle damage from snakebites, according to a study published in Trends in Biotechnology. Scientists from the University of Reading and ...

A Moderna spokesperson said the company is aware of the lawsuit and will defend itself. Spokespeople for Pfizer, BioNTech and Johnson & Johnson did not immediately respond to requests for comment.

You may have seen ads for a new, lower-dose Moderna COVID vaccine marketed to "the senior class" - adults 65 and older. The new vaccine, which goes by mRNA-1283 or mNexspike, was approved by the U.S.